Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2012
11/21/2012CN102783647A Preparation method of kudzu root isoflavone powder
11/21/2012CN102783646A Preparation method for kudzuvine root flavone lozenge
11/21/2012CN102365089B Medicine for preventing and treating alzheimer's disease and preparative method thereof
11/21/2012CN102351958B Preparation method and application of astragalus polysaccharide-calcium complex
11/21/2012CN102327497B Method for preparing traditional Chinese medicine lotion for treating eclamptic bedsore
11/21/2012CN102327210B Vinpocetine suspension injection
11/21/2012CN102302453B Paroxetine hydrochloride liposome solid preparation
11/21/2012CN102283858B Application of lycium barbarum polysaccharides for preparing drugs for preventing and treating chronic stress and posttraumatic stress disorder
11/21/2012CN102274400B Dry jewel orchid and processing method thereof
11/21/2012CN102268054B Beta-cytidine-5 '-triphosphoarginine derivative ester and its preparation method and use
11/21/2012CN102247330B Sustained release tablet prepared from raw material of safflower yellow and preparation method thereof
11/21/2012CN102247324B Flumazenil liposome injection
11/21/2012CN102190644B Chiral 3-hydroxypyridin-4-one derivatives, synthesis and application thereof
11/21/2012CN102178919B Oral Chinese medicine for relieving alcoholism
11/21/2012CN102159199B Composition containing 4-o-methylhonokiol for treating or preventing amyloid-related diseases
11/21/2012CN102134267B Novel dehydropachymic acid
11/21/2012CN102085183B Asarin lipid nanospheres and method for preparing same
11/21/2012CN102008474B Application of nitidine chloride to preparation of medicament for treating autoimmune disease and graft rejection disease
11/21/2012CN102008468B Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases
11/21/2012CN101965187B Crystalline micropowder particles
11/21/2012CN101961311B 5alpha-androstane (alkyl)-3beta,5,6beta-triol injection and preparation method thereof
11/21/2012CN101953999B Medicinal composition for treating paralysis and preparation method thereof
11/21/2012CN101921314B Brain-targeting neurotrophic factor fusion polypeptide for preventing and treating Alzheimer's disease and preparation method
11/21/2012CN101903342B Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
11/21/2012CN101897675B Solid oral medicinal composition containing valsartan or pharmaceutically acceptable salts of valsartan
11/21/2012CN101610764B Benzamide derivatives as EP4 receptor agonists
11/21/2012CN101602708B Aryl alkanol piperidine derivative and application thereof as antidepressive medicine
11/21/2012CN101559168B Pharmaceutical composition for invigorating Qi, tonifying blood and nourishing liver and kidney as well as preparation method and application thereof
11/21/2012CN101557810B Novel 2 -imidazoles as ligands for trace amine associated receptors (taar)
11/21/2012CN101432280B Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
11/21/2012CN101346366B Benzochromene derivatives
11/21/2012CN101327010B Method for preparing amber ginseng
11/21/2012CN101304769B Acute treatment of social phobia
11/21/2012CN101229169B Sustained release formulations comprising lamotrigine
11/20/2012US8314268 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
11/20/2012US8314234 Bicyclic pyrimidine kinase inhibitors
11/20/2012US8314129 Optical isomers of an iloperidone metabolite
11/20/2012US8314126 Disubstituted phenylpiperdines/piperazines as modulators of dopamine neurotransmission
11/20/2012US8314117 CGRP receptor antagonists
11/20/2012US8314115 Method of treating movement disorders using barbituric acid derivatives
11/20/2012US8314109 6-heterocyclic-imidazo[1,2-α]pyridine-2-carboxamide derivatives, preparation and therapeutic use thereof
11/20/2012US8314092 Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity H1 inverse agonists/5-HT2A antagonists
11/20/2012US8314074 Formulations comprising antisense nucleotides to connexins
11/20/2012US8314067 Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
11/20/2012US8314066 GH secretagogues and uses thereof
11/20/2012US8313769 Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
11/20/2012US8313741 Use of medulliadrenal chromaffin cells or peptide functional cells
11/20/2012CA2710054C Oil extract from a bivalve mollusc that is rich in n-acylethanolamides
11/20/2012CA2634811C Novel modifications to 2-amino-4-(4-fluorobenzylamino) -1- ethoxycarbonyl-aminobenzene and processes for preparing said compound
11/20/2012CA2616971C A composition comprising an extract of red mold rice for treatment of alzheimer's disease
11/20/2012CA2502544C Screening molecules with anti-prion activity: kits, methods and screened molecules
11/20/2012CA2482466C Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
11/20/2012CA2318095C Methods of treating tardive dyskinesia and other movement disorders
11/15/2012WO2012154986A1 Implantable polymeric device for sustained release of sufentanil
11/15/2012WO2012154967A1 Proteostasis regulators
11/15/2012WO2012154956A2 Anxiolytic effect of pterostilbene
11/15/2012WO2012154837A2 The use of ketone esters for prevention of cns oxygen toxicity
11/15/2012WO2012154807A1 Use of jasmonates for modulating melatonin production and calcification of the pineal gland
11/15/2012WO2012154728A1 Deuterated n-butyl bumetanide
11/15/2012WO2012154354A1 Cgrp receptor antagonists
11/15/2012WO2012154174A1 Methods for treating insomnia
11/15/2012WO2012153827A1 Stable drug composition
11/15/2012WO2012153796A1 Pyrimido-diazepinone compound
11/15/2012WO2012153729A1 Heteroaromatic ring derivative
11/15/2012WO2012152983A1 Phenyl- sulfonyl derivatives as mediators of trpa1 receptor activity for the treatment of pain
11/15/2012WO2012152915A1 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
11/15/2012WO2012152854A1 Metabotropic glutamate receptor modulators
11/15/2012WO2012152739A1 Compounds with thioredoxin-like fold domain for the treatment of degenerative disorders
11/15/2012WO2012151958A1 Low-toxic 3-pyrazole carboxylic acid amides, preparation methods and uses thereof in manufacture of medicines as cb1 receptor inhibitors
11/15/2012WO2012151640A1 Methods for preparing naphthyridines
11/15/2012WO2012129324A9 6-substituted estradiol derivatives for use in remyelination of nerve axons
11/15/2012WO2012095548A3 Dream inhibitors for treating neurodegenerative diseases
11/15/2012WO2012046250A8 Polymorphic forms of o-desmethyl-venlafaxine succinate
11/15/2012WO2011106729A3 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
11/15/2012US20120289614 Functionalized biodegradable triclosan monomers and oligomers for controlled release
11/15/2012US20120289604 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
11/15/2012US20120289601 Gastric Retained Gabapentin Dosage Form
11/15/2012US20120289597 Nitric oxide amino acid esters for the treatment of chronic pain
11/15/2012US20120289594 Oral dosage form
11/15/2012US20120289587 Compounds that modulate intracellular calcium
11/15/2012US20120289583 Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
11/15/2012US20120289578 Use of rna interference for treating or reducing pain
11/15/2012US20120289576 Process for Forming Amorphous Atorvastatin
11/15/2012US20120289572 Nicotinic Acetylcholine Receptor Sub-Type Selective Amides of Diazabicycloalkanes
11/15/2012US20120289557 Protein Synthesis Required for Long-Term Memory is Induced by PKC Activation on Days Preceding Associative Learning
11/15/2012US20120289556 Methods for Treating Conditions Caused by Higher-Than-Normal Dopaminergic Activity In Basal Ganglia
11/15/2012US20120289553 Oral liquid pharmaceutical composition of nifedipine
11/15/2012US20120289552 Aryl ureas with angiogenesis inhibiting activity
11/15/2012US20120289548 Oligomer-opioid agonist conjugates
11/15/2012US20120289546 Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine
11/15/2012US20120289536 Pharmaceutical Compositions Comprising Colloidal Silicon Dioxide
11/15/2012US20120289534 Package for improved treatment of conditions
11/15/2012US20120289528 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
11/15/2012US20120289526 Imidazolidinedione derivatives
11/15/2012US20120289524 Pyrrolo [3,2-e] [1,2,4] triazolo [1,5-a] pyrimidines derivatives as inhibitors of microglia activation
11/15/2012US20120289523 Pyrrolo [3,2-e] [1,2,4] triazolo [1,5-a] pyrimidines derivatives as inhibitors of microglia activation
11/15/2012US20120289518 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
11/15/2012US20120289515 Combination therapy for cognitive distortions, resisting relapse of unipolar non-psychotic depression
11/15/2012US20120289514 Pharmaceutical composition for treating alcohol dependency
11/15/2012US20120289513 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 1833